Mary Lou Siefert1, Fangxin Hong, Bianca Valcarce, Donna L Berry. 1. Author Affiliations: Phyllis F. Cantor Center for Research in Nursing and Patient Care Services (Drs Siefert and Berry and Ms Valcarce) and Department of Biostatistics and Computational Biology (Dr Hong), Dana Farber Cancer Institute, Boston, Massachusetts.
Abstract
BACKGROUND: Insomnia, the most commonly reported sleep-wake disturbance in people with cancer, has an adverse effect on quality of life including emotional well-being, distress associated with other symptoms, daily functioning, relationships, and ability to work. OBJECTIVE: The aim of this study was to describe the content of discussions between clinicians and 120 patients with self-reported insomnia and to examine the associations of sociodemographic, clinical, and environmental factors with insomnia. METHODS: A secondary analysis was conducted with self-reported symptom data and sociodemographic, clinical, and environmental factors. Recordings of clinician and patient discussions during clinic visits were examined by conducting a content analysis. RESULTS: Severe insomnia was more likely to be reported by women, minority, and lower-income individuals. Seven major topics were identified in the discussions. The clinicians did not always discuss insomnia; discussion rates differed by diagnosis and clinical service. CONCLUSIONS: Reporting of insomnia by the patient and clinician communication about insomnia may have differed by demographic and clinical characteristics. Clinicians attended to insomnia about half the time with management strategies likely to be effective. Explanations may be that insomnia had a low clinician priority for the clinic visit or lack of clear evidence to support insomnia interventions. IMPLICATIONS FOR PRACTICE: A better understanding is needed about why insomnia is not addressed even when reported by patients; it is well known that structured assessments and early interventions can improve quality of life. Research is warranted to better understand potential disparities in cancer care.
BACKGROUND:Insomnia, the most commonly reported sleep-wake disturbance in people with cancer, has an adverse effect on quality of life including emotional well-being, distress associated with other symptoms, daily functioning, relationships, and ability to work. OBJECTIVE: The aim of this study was to describe the content of discussions between clinicians and 120 patients with self-reported insomnia and to examine the associations of sociodemographic, clinical, and environmental factors with insomnia. METHODS: A secondary analysis was conducted with self-reported symptom data and sociodemographic, clinical, and environmental factors. Recordings of clinician and patient discussions during clinic visits were examined by conducting a content analysis. RESULTS: Severe insomnia was more likely to be reported by women, minority, and lower-income individuals. Seven major topics were identified in the discussions. The clinicians did not always discuss insomnia; discussion rates differed by diagnosis and clinical service. CONCLUSIONS: Reporting of insomnia by the patient and clinician communication about insomnia may have differed by demographic and clinical characteristics. Clinicians attended to insomnia about half the time with management strategies likely to be effective. Explanations may be that insomnia had a low clinician priority for the clinic visit or lack of clear evidence to support insomnia interventions. IMPLICATIONS FOR PRACTICE: A better understanding is needed about why insomnia is not addressed even when reported by patients; it is well known that structured assessments and early interventions can improve quality of life. Research is warranted to better understand potential disparities in cancer care.
Authors: Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Amy K Otto; Brian D Gonzalez; Richard E Heyman; Susan T Vadaparampil; Lee Ellington; Maija Reblin Journal: Psychooncology Date: 2019-11-12 Impact factor: 3.894
Authors: Sheila N Garland; Kelly Trevino; Kevin T Liou; Philip Gehrman; Eugenie Spiguel; Jodi MacLeod; Desirée A H Walker; Betsy Glosik; Christina Seluzicki; Frances K Barg; Jun J Mao Journal: J Cancer Surviv Date: 2021-02-19 Impact factor: 4.442
Authors: Julie L Otte; Janet S Carpenter; Shalini Manchanda; Kevin L Rand; Todd C Skaar; Michael Weaver; Yelena Chernyak; Xin Zhong; Christele Igega; Carol Landis Journal: Cancer Med Date: 2014-11-30 Impact factor: 4.452
Authors: Ivan H C Wu; Diwakar D Balachandran; Saadia A Faiz; Lara Bashoura; Carmen P Escalante; Ellen F Manzullo Journal: J Pain Symptom Manage Date: 2021-08-01 Impact factor: 3.612
Authors: Susan Grayson; Susan Sereika; Caroline Harpel; Emilia Diego; Jennifer G Steiman; Priscilla F McAuliffe; Susan Wesmiller Journal: Support Care Cancer Date: 2021-07-10 Impact factor: 3.603
Authors: Donna L Berry; Fangxin Hong; Barbara Halpenny; Anne Partridge; Erica Fox; Jesse R Fann; Seth Wolpin; William B Lober; Nigel Bush; Upendra Parvathaneni; Dagmar Amtmann; Rosemary Ford Journal: BMC Cancer Date: 2014-07-12 Impact factor: 4.430